adjuster11

I’m new to these forums (have only been approved to post for a week) so have been surveying all the incredible information available –
I’ve seen references on other posts indicating CholangioCarcinoma is more widespread in the Middle East and Far East and your post shows shows important research is being done in thos areas – I personally find this interesting because I lived/worked and travelled extensively in Europe, Middle East and Far East during the 1950’s, 1960’s and 1970’s so I’m curious as to whether I may have picked up some of the referenced liver flukes out there!!!
Thanks so much for your information –
Best Regards, Don

I’m newly diagnosed and my daughter and I posted some information on your “Introductions” board today – I’m writing thi post to provide some additional information to ask a couple of questions – I’m not quite sure whether this should be posted on your “Introductions” board or on some other board so I’d appreciate it if someone could advise me as to where future messages should be located –
My original Tumor Marker 19-9 showed a 357 count – The second Tumor Marker which was done after two Chemotherapy cycles (one a week for two weeks and then skip a week to complete a cycle) showed a 333 count –
The CT scan (done November 4,2013) also done after two Chemotherapy cycles read, in part, as follows:
Subpleural nodule located posteriorly within the left lower lobe is 8 x 14 mm, previously {on first CT scan done August 30 2013) approximately 6 x 10 mm – Nodule located posteriorly in the right base is 4 x 10 mm, previously 6 mm –

Confluent hypoattenuating nodules or masses are demonstrated within the liver. This is most prominent throughout the left lobe and within the anterior right lobe as evident previously – 12 mL low attenuation lesion within the posterior right lobe is new – Enlarged gastrohepatic nodes are present – 13 x 14 mm node as previously approxinmately 9 x 12 mm – Mildly enlarged periportal nodes are present – 12 mL low-attenuation lesion within the posterior right lobe is new –

Spleen, adnenal glands pancreas are stable in appearance . No hydrohephrosis is present – Low-attenuation left renal lesion laterally is 14 x 21 mm, unchanged –

IMPRESSION
Extensive confluent low-attenuation masses throughout the liver most prominent anteriorly, overall slightly increased from prior study –
Gastrohepatic and periportal mild adenopathy, slightly increased –
Small lower lobe pulmonary nodules, slightly increased –

I obviously don’t understand this report and I hope I’m not violating any rules by posing this information on the board – If so, please tell me and I promise not to do this again –
I’d appreciate it if someone would be kind enough to answer a couple of questions for me – First, what do the Tumor Marker numbers mean? What is being counted?
Secondly, although the report seems to me to indicate the nodules have grown, my Oncologist indicated the nodules were stable and he was not concerned about the minimal growth indicated on the report –

As I mentioned in my earlier Introduction post today I am totally new and know nothing except what my daughter has dug up on the internet so if anyone could provide me with some clarification I would be most grateful –
Regards to all, Don